October 10, 2018 Clinical Research/Diagn. Lab Top-10 Mass Spectrometry Product Launch

Waters New RenataDX Screening System Delivers Fast, Accurate Results for Clinical Scientists

In Vitro Diagnostic Device Designed for Dried Blood Spot Analysis MILFORD, Mass.–(BUSINESS WIRE)–Oct. 10, 2018– Waters Corporation (NYSE:WAT) introduced the RenataDX™ Screening System, a flow-injection tandem mass spectrometry (FIA-MS/MS) system for rapid high-throughput analysis of extracted dried blood spots and other human biological matrices. Waters New RenataDX Screening System Delivers Fast, Accurate Results for Clinical Scientists (Photo: Business... Read more

October 8, 2018 Clinical Research/Diagn. Lab Top-10

Combined testing of troponin and copeptin at admission shows potential to save time and costs in acute care and for the entire hospital stay

Combined testing of troponin and copeptin at admission shows potential to save time and costs in acute care and for the entire hospital stay Analysis shows the earlier identification and rule-out of patients without acute myocardial infarction are the key enablers of positive economic outcome HENNIGSDORF, Germany, Oct. 8, 2018 /PRNewswire/ — A cost analysis among... Read more

October 2, 2018 Clinical Research/Diagn. Lab Top-10 Life Science Tools M&A, Partnerships

Seoul St. Mary's Hospital and Singapore General Hospital Join Thermo Fisher Scientific's Next-Generation Sequencing Center of Excellence Program

Seoul St. Mary’s Hospital and Singapore General Hospital Join Thermo Fisher Scientific’s Next-Generation Sequencing Center of Excellence Program Newest partners announced during company’s Global Strategic Partner Summit in Boston BOSTON, Oct. 2, 2018 /PRNewswire/ — Seoul St. Mary’s Hospital, part of Catholic Medical Center (CMC) in South Korea, and Singapore General Hospital are the newest... Read more

September 28, 2018 Clinical Research/Diagn. Licensing, IP, and Legal

QIAGEN receives FDA approval to expand use of EGFR test in lung cancer

Approval allows use of therascreen® EGFR RGQ PCR Kit as a companion diagnostic for Pfizer’s VIZIMPRO® (dacomitinib) in patients with non-small cell lung cancer Germantown, Maryland, and Hilden, Germany, September 28, 2018 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that the U.S. Food and Drug Administration (FDA) has approved a PMA Supplement... Read more

September 27, 2018 Clinical Research/Diagn. Informatics & Software Life Science Tools M&A, Partnerships

Baylor-Hopkins Clinical Genome Center (BHCGC) Announces Major Role in National Institutes of Health Precision Medicine Research Effort

DNAnexus selected by BHCGC to serve as its primary portal for communication and data sharing with the All of Us Research Program. September 27, 2018 08:00 AM Eastern Daylight Time MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–The Baylor College of Medicine Human Genome Sequencing Center (HGSC) today announced participation in the National Institutes of Health All of Us Research Program, a large-scale effort to advance... Read more

September 27, 2018 Clinical Research/Diagn.

Bio-Techne Announces Cell and Gene Therapy Initiative

 Download as PDF SEPTEMBER 27, 2018 MINNEAPOLIS, Sept. 27, 2018 /PRNewswire/ — Bio-Techne, a global leader of research and manufacturing-grade reagents, has announced a corporate initiative to advance cell and gene therapy research and ex vivo cell processing. Through strategic acquisitions and internal scientific innovation, Bio-Techne has become uniquely positioned to provide a comprehensive, innovative, and flexible... Read more

September 25, 2018 Clinical Research/Diagn. Lab Top-10 Life Science Tools

Game Changing Tuberculosis Assay Validated for Illumina’s MiSeq® Platform

Next Generation Sequencing (NGS) Kit to Improve Speed and Accuracy of M. Tuberculosis (MTB) Drug Sensitivity Testing (DST) at a Fraction of the Current Cost of Sequencing BETHESDA, Maryland, Sept. 25, 2018 /PRNewswire/ — Longhorn Vaccines and Diagnostics LLC (LHNVD), a private pre-analytical systems and molecular solutions company, is pleased to announce the validation of its newest technology,... Read more

September 20, 2018 Cell Analysis Tools Clinical Research/Diagn. M&A, Partnerships

Early Access to IsoPlexis’ Single Cell Analytics Platform Enhances Cell Therapy Program at World-renowned Research and Treatment Center

IsoPlexis’ groundbreaking platform has been shown in key studies to predict patient response to cell therapy The IsoLight® platform: • profiles responses at the single cell level enabling researchers to generate a precise functional patient signature to help predict and understand complex patient response to cancer immunotherapies • advances high-need areas of cell therapy research,... Read more